Compare Amphastar Pharmaceuticals Inc (AMPH) vs Godaddy Inc (GDDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Godaddy Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $863.95M), while Godaddy Inc trades at $90.75 (market cap $11.59B). The key difference: Godaddy Inc is far larger — about 13.4× Amphastar Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| AMPH | GDDY | |
|---|---|---|
Market Cap | $863.95M | $11.59B |
Sector | Health | Technology |
52-Week High | $30.81 | $148.88 |
52-Week Low | $16.87 | $75.07 |
Enterprise Value | $1.26B | $14.27B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.
Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.
GoDaddy (GDDY) trades at $91.07, up 0.8% today, with a neutral technical signal and strong fundamentals including a P/E of 13.53 and net income margin of 17.83%. Recent earnings have consistently beaten estimates, with Q2 2026 EPS of $1.83 surpassing the $1.69 expectation. However, the stock faces headwinds from multiple law firm investigations into potential securities violations, as reported by PRNewsWire and GlobeNewsWire in early August 2026.
The outlook is mixed: analyst consensus is bullish with a $112.13 price target (56.76% buy ratings), but legal risks and a high debt load pose concerns. Revenue growth is steady, projected at $5.1B for 2026, yet investor sentiment is cautious due to ongoing litigation. Upside depends on clearing legal hurdles and maintaining earnings momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Godaddy Inc
GoDaddy is a provider of domain registration and aftermarket services, website hosting, security, design, and business productivity tools, commerce solutions, and domain registry services. The company primarily targets micro- to small businesses, website design professionals, registrar peers, and domain investors. Since acquiring payment processing platform Poynt in 2021, the company has expanded into omnicommerce solutions, including offering an online payment gateway and offline point-of-sale devices.
Read more on GDDY →
